3 research outputs found

    Gonadotrophin‐releasing hormone analogues for endometriosis:bone mineral density

    No full text
    This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effectiveness and safety of gonadotrophin‐releasing hormone analogues (GnRHas) in the treatment of endometriosis

    External validation of a prediction model to select the best day-three embryo for transfer in in vitro fertilization or intracytoplasmatic sperm injection procedures

    No full text
    \u3cp\u3eObjective: To evaluate the multivariate embryo selection model by van Loendersloot et al. (2014) (VL) in a different geographical context. Design: This is a retrospective external validation study of a 5-year cohort of women undergoing in vitro fertilization or intracytoplasmatic sperm injection. Setting: Two outpatient fertility clinics. Patient(s): A total of 1,197 women who underwent 1,610 fresh in vitro fertilization or intracytoplasmatic sperm injection cycles with single embryo transfer were included. Intervention(s): None. Main Outcome Measure(s): The area under the receiver operating characteristics curve for diagnostic efficacy was used to assess the discriminative value of the model. Calibration for testing the validity of the VL model was performed using the Hosmer-Lemeshow goodness-of-fit test and a calibration plot. Result(s): Three hundred thirty-three patients (21%) achieved a viable pregnancy of at least 11 weeks. The area under the receiver operating characteristics curve using the VL model was 0.68. No significant difference between the predicted implantation rate and the observed implantation rates was showed using the Hosmer-Lemeshow (X\u3csup\u3e2\u3c/sup\u3e= 6.70). The calibration plot showed an intercept of the regression line of 0.34 and the estimated slope was 0.72. Conclusion: The investigated VL model was able to distinguish between higher and lower implantation potential of embryos in our clinical setting.\u3c/p\u3

    Does endometrial scratching increase the rate of spontaneous conception in couples with unexplained infertility and a good prognosis (Hunault > 30%)? Study protocol of the SCRaTCH-OFO trial:a randomized controlled trial

    No full text
    \u3cp\u3eBACKGROUND: In the Netherlands, couples with unexplained infertility and a good prognosis to conceive spontaneously (i.e. Hunault > 30%) are advised to perform timed intercourse for at least another 6 months. If couples fail to conceive within this period, they will usually start assisted reproductive technology (ART). However, treatment of unexplained infertility by ART is empirical and can involve significant burdens. Intentional endometrial injury, also called 'endometrial scratching', has been proposed to positively affect the chance of embryo implantation in patients undergoing in vitro fertilization (IVF). It might also be beneficial for couples with unexplained infertility as defective endometrial receptivity may play a role in these women. The primary aim of this study is to determine whether endometrial scratching increases live birth rates in women with unexplained infertility.\u3c/p\u3e\u3cp\u3eMETHOD: A multicentre randomized controlled trial will be conducted in Dutch academic and non-academic hospitals starting from November 2017. A total of 792 women with unexplained infertility and a good prognosis for spontaneous conception < 12 months (Hunault > 30%) will be included, of whom half will undergo endometrial scratching in the luteal phase of the natural cycle. The women in the control group will not undergo endometrial scratching. According to Dutch guidelines, both groups will subsequently perform timed intercourse for at least 6 months. The primary endpoint is cumulative live birth rate. Secondary endpoints are clinical and ongoing pregnancy rate; miscarriage rate; biochemical pregnancy loss; multiple pregnancy rate; time to pregnancy; progression to intrauterine insemination (IUI) or IVF; pregnancy complications; complications of endometrial scratching; costs and endometrial tissue parameters associated with reproductive success or failure. The follow-up duration is 12 months.\u3c/p\u3e\u3cp\u3eDISCUSSION: Several small studies show a possible beneficial effect of endometrial scratching in women with unexplained infertility trying to conceive naturally or through IUI. However, the quality of this evidence is very low, making it unclear whether these women will truly benefit from this procedure. The SCRaTCH-OFO trial aims to investigate the effect of endometrial scratching on live birth rate in women with unexplained infertility and a good prognosis for spontaneous conception < 12 months.\u3c/p\u3e\u3cp\u3eTRIAL REGISTRATION: NTR6687 , registered August 31st, 2017.\u3c/p\u3e\u3cp\u3ePROTOCOL VERSION: Version 2.6, November 14th, 2018.\u3c/p\u3
    corecore